U.S. Veterinary Intravenous (iv) Solutions Market Size & Outlook
U.S. veterinary intravenous (iv) solutions market, 2018-2030 (US$M)
Related Markets
U.S. veterinary intravenous (iv) solutions market highlights
- The U.S. veterinary intravenous (iv) solutions market generated a revenue of USD 460.2 million in 2023 and is expected to reach USD 742.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, isotonic crystalloids was the largest revenue generating product in 2023.
- Dextrose solutions is the most lucrative product segment registering the fastest growth during the forecast period.
Veterinary intravenous (iv) solutions market data book summary
| Market revenue in 2023 | USD 460.2 million |
| Market revenue in 2030 | USD 742.0 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Isotonic crystalloids |
| Fastest growing segment | Dextrose solutions |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition |
| Key market players worldwide | Merck & Co Inc, Baxter International Inc, Dechra Veterinary Products, Sypharma, B. Braun, Woods Consulting, Fresenius Kabi, Fresenius SE & Co KGaA |
Other key industry trends
- In terms of revenue, U.S. accounted for 29.1% of the global veterinary intravenous (iv) solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. veterinary intravenous (iv) solutions market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 247.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Intravenous (IV) Solutions Market Scope
Veterinary Intravenous (IV) Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. veterinary intravenous (iv) solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary intravenous (iv) solutions market will help companies and investors design strategic landscapes.
Isotonic crystalloids was the largest segment with a revenue share of 42.42% in 2023. Horizon Databook has segmented the U.S. veterinary intravenous (iv) solutions market based on isotonic crystalloids, synthetic colloids, blood products, dextrose solutions, parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Veterinary Intravenous (IV) Solutions Product Outlook (Revenue, USD Million, 2018-2030)
- Isotonic crystalloids
- Synthetic colloids
- Blood products
- Dextrose solutions
- Parenteral nutrition
- U.S. Veterinary Intravenous (IV) Solutions Indication Outlook (Revenue, USD Million, 2018-2030)
- Diabetic Ketoacidosis
- Pancreatitis
- Anthrax
- Chronic Kidney Disease
- Others
- U.S. Veterinary Intravenous (IV) Solutions Animal type Outlook (Revenue, USD Million, 2018-2030)
- Companion Animals
- Production Animals
- U.S. Veterinary Intravenous (IV) Solutions End Use Outlook (Revenue, USD Million, 2018-2030)
- Veterinary Hospitals
- Research Institutes
- Others
Reasons to subscribe to U.S. veterinary intravenous (iv) solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. veterinary intravenous (iv) solutions market databook
-
Our clientele includes a mix of veterinary intravenous (iv) solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary intravenous (iv) solutions market , including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary intravenous (iv) solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. veterinary intravenous (iv) solutions market size, by product, 2018-2030 (US$M)
U.S. Veterinary Intravenous (IV) Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
